Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
LABS | Toronto | CAD | Real-time | |
MEDIF | OTC Markets | USD | Delayed |
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Name | Age | Since | Title |
---|---|---|---|
Christopher David Taves | - | 2020 | Independent Chairman of the Board |
David A. Pidduck | - | 2022 | CEO & Director |
Carolina Landolt-Marticorena | - | 2019 | Member of the Science Advisory Board |
Matt Archibald | - | 2019 | Member of the Science Advisory Board |
Markus Roggen | - | 2019 | Member of the Science Advisory Board |
Arshad Hack | - | 2019 | Member of the Science Advisory Board |
Leslie Brown | - | 2019 | Member of the Science Advisory Board |
Jerry King | - | 2019 | Member of the Science Advisory Board |
Shelley Martin | - | 2020 | Independent Director |
Christopher Halyk | - | 2020 | Independent Director |
Michael Scott Bumby | 59 | 2023 | Independent Director |
Miriam McDonald | - | 2018 | Member of the Science Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review